Eberhard Karls Universität Tübingen
383 papers found
Diagnostic and prognostic classification of atypical spitzoid tumours based on histology and genomic aberrations: A prospective cohort study with long-term follow-up
Association between Immune-Related Adverse Events and Survival in 319 Stage IV Melanoma Patients Treated with PD-1-Based Immunotherapy: An Approach Based on Clinical Chemistry
Cutaneous melanoma attributable to UVR exposure in Denmark and Germany
Individualized Proteogenomics Reveals the Mutational Landscape of Melanoma Patients in Response to Immunotherapy
Diffuse PRAME Expression Is Highly Specific for Thin Melanomas in the Distinction from Severely Dysplastic Nevi but Does Not Distinguish Metastasizing from Non-Metastasizing Thin Melanomas
The impact of the COVID‐19 pandemic on diagnostic delay of skin cancer: a call to restart screening activities
Not all melanomas are created equal: a review and call for more research into nodular melanoma
Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943–2036
Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib: Results from a multicentre, open-label, randomised, phase III study (COLUMBUS)
5-Year Outcomes with Cobimetinib Plus Vemurafenib in BRAFV600 Mutation-Positive Advanced Melanoma: Extended Follow-Up of the coBRIM Study
Psychological Distress of Metastatic Melanoma Patients during Treatment with Immune Checkpoint Inhibitors: Results of a Prospective Study
A multicenter study of nevus‐associated melanoma versus de novo melanoma, tumor thickness and body site differences
Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma—Old Myth or New Logos?
Improved protection of outdoor workers from solar ultraviolet radiation: position statement
The evolving field of Dermato‐oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV–UEMS and EORTC Cutaneous Lymphoma Task Force
Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion
Influence of 18F-FDG PET/CT on clinical management and outcome in patients with advanced melanoma not primarily selected for surgery based on a linked evidence approach
Prognostic factors in 161 patients with mucosal melanoma: a study of German Central Malignant Melanoma Registry
Molecular genetics of cutaneous squamous cell carcinoma: perspective for treatment strategies
Late recurrence of melanoma after 10 years – Is the course of the disease different from early recurrences?
Missing publications? Search for publications with a matching author name.